INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 December 2011
Total net assets |
£102.8m |
NAV per share |
185.0p |
Share price |
159.0p |
Total value of unquoted investments |
£17.9m |
Total number of portfolio companies |
69 |
Cash |
3% NAV |
Cash committed and reserved to unquoted investments |
(9)% NAV |
Portfolio companies with < 1 year of cash |
13.3% NAV |
Top Ten Holdings
Company Name |
% NAV |
Gilead Sciences |
5.6 |
Amgen |
5.4 |
Micromet |
4.7 |
Teva |
4.2 |
Insulet |
4.1 |
Pharmaxis |
3.5 |
Celgene |
3.3 |
Shire |
2.9 |
Alexion |
2.9 |
EUSA |
2.9 |
|
----------- |
Total |
39.5 |
Geographical Allocation |
% |
United States |
73 |
Europe |
15 |
Israel |
5 |
Australia |
4 |
Cash |
3 |
|
----------- |
Total |
100 |
Quoted/Unquoted allocation |
% |
Quoted |
80 |
Unquoted |
17 |
Cash |
3 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
23 JANUARY 2012